Vericiguat news

All news on Vericiguat (also known as VERQUVO): plants, production capacities, investments and involved companies in Europe.

30 August 2025
Bayer Presents VICTOR Phase III Trial Results for Vericiguat at ESC Congress 2025
Vericiguat didn't reduce primary endpoint risk in HFrEF patients but showed fewer cardiovascular deaths. Safety profile consistent with previous trials.

Who will be producing Vericiguat in the future?

Find out with chemXplore Analytics